Wright, Julie Korol
Hayford, Kyla
Tran, Vanessa
Al Kibria, Gulam Muhammed
Baqui, Abdullah
Manajjir, Ali
Mahmud, Arif
Begum, Nazma
Siddiquee, Mashuk
Kain, Kevin C.
Farzin, Azadeh
Funding for this research was provided by:
Canadian Institutes of Health Research (MOP-13721)
Canadian Institutes of Health Research (MOP-115160)
Canadian Institutes of Health Research (MOP-136813)
Canadian Institutes of Health Research (FDN-148439)
Canada Research Chair Program
Johns Hopkins University (US) Mentored Career Development Award
National Institute of Child Health and Human Development (K08 HD 073315)
Article History
Received: 20 March 2017
Accepted: 7 March 2018
First Online: 23 March 2018
Ethics approval and consent to participate
: Ethical approval for this study was granted from the University Health Network Research Ethics Board, University of Toronto; the Johns Hopkins Bloomberg School of Public Health; the Bangladesh Institute of Child Health Ethical Review Committee; and the Sylhet MAG Osmani Medical College Ethical Review Committee. Parents or guardians of enrolled infants provided written informed consent.
: Not applicable.
: K.C.K. is listed as an inventor on patents related to the use of angiopoietin markers, entitled “Angiopoietin-1 and -2 biomarkers for infectious diseases that compromise endothelial integrity” (application no. WO2009059404) and “Biomarkers for early determination of a critical or life threatening response to illness and monitoring response to treatment” (application no. CA2769433). For the remaining authors, no competing interests were declared.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.